Molecular pathophysiology of indolent lymphoma

Haematologica

Volumn 85, Issue 2, 2000, Pages 195-201

  Capello, Daniela ^a   Gaidano, Gianluca ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Indolent lymphomas

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HISTOGENESIS; HUMAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOPHYSIOLOGY;

CHROMOSOME ABERRATIONS; DNA, NEOPLASM; HUMANS; LYMPHOMA;

EID: 0034129739     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. th ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 2131-45.
2. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997(special issue):417-74.
3. Gamberi B, Gaidano C, Parsa N, et al. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood 1997; 89:975-9.
4. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
5. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88:5413-7.
6. Gaidano G, Newcomb EW, Gong JZ, et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994; 144:1312-9.
7. Schena M, Larsson LG, Gottardi D, et al. Growth-and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992; 79: 2981-9.
8. Starostik P, Manshouri T, O'Brien S, et al. Deficiency of the ATM protein expression defines an aggressive sub-group of B-cell chronic lymphocytic leukemia. Cancer Res 1998; 58:4552-7.
9. Bullrich F, Rasio D, Kitada S, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999; 59:24-7.
10. Stankovic T, Weber P, Stewart G, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia. Lancet 1999; 353:26-9.
11. Autio K, Aalto Y, Frarssila K, Elonen E, Joensuu H, Knuutila S. Low number of DNA copy number changes in small lymphocytic lymphoma. Haematologica 1998; 83:690-2.
12. Juliusson G, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990; 323:720-4.
13. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JP. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 1992; 79:1796-801.
14. Hjalmar V, Kimby E, Matutes E, et al. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders. Haematologica 1998; 83:602-9.
15. Kalachikov S, Migliazza A, Cayanis E, et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 1997; 42:369-77.
16. Cuneo A, Bigoni R, Rigolin GM, et al. 13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathologic features. Haematologica 1999; 84:589-93.
17. Iida S, Rao PH, Nallasivam P, et al. The t(9;14) (p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996; 88:4110-7.
18. Neurath MF, Stuber ER, Strober W. BSAP: a key regulator of B-cell development and differentiation. Immunol Today 1995; 16:564-9.
19. Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) of human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41:889-906.
20. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoints of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226:1097-9.
21. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998; 16:395-419.
22. Garcia-Sanz R, Vargas Montero M, Gonzalez Diaz M, et al. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype. Haematologica 1998; 83:209-16.
23. Reed JC, Stein C, Subasinghe C. Antisense-mediated inhibition of BCL-2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 1990; 50:6565-70.
24. McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57:79-88.
25. McDonnel TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254-6.
26. Gaidano G, Hautschein RS, Parsa NZ, et al. Deletions involving two distinct regions of 6q in B-cell non Hodgkin's lymphoma. Blood 1992; 80:1781-7.
27. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82:2289-95.
28. INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91:2977-84.
29. Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95:651-9.
30. Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80:758-67.
31. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224:1403-6.
32. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell P, Croce CM. Clustering of breakpoints on chromosome 11 in human B cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315:340-3.
33. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991; 350:512-5.
34. Jiang W, Kahn SM, Zhou P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8:3447-57.
35. Bodrug S, Warner B, Bath M, Lindeman G, Harris A, Adams J. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13:2124-30.
36. Lovec H, Grzeschiczek A, Kowalsky MB, Möröy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphomas in transgenic mice. EMBO J 1994; 13:3487-95.
37. Louie DC, Offit K, Jaslow R, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892-9.
38. Wlodarska I, Pittaluga S, Hagemeijer A, De Wolf-Peeters C, Van Den Berghe H. Secondary chromosome changes in mantle cell lymphoma. Haematologica 1999; 84:594-9.
39. Parsonnet J, Hansen S, Rodriguez L, et al. Heticobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267-71.
40. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575-7.
41. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphoma. Blood 1999; 93:3601-9.
42. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18:5785-94.
43. Ott G, Kalla J, Steinhoff A, et al. Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 1998; 153: 689-94.
44. Willis TC, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96:35-45.
45. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999; 22:63-8.
46. Fakruddin JM, Chaganti RS, Murty W. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell 1999; 97:683-4.
47. Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995; 86:4587-93.
48. Gaidano G, Volpe G, Pastore C, et al. Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas. Am J Hematol 1997; 56:206-13.
49. Gaidano G, Capello D, Gloghini A, et al. Frequent mutation of BCL-6 proto-oncogene in high grade, but not low grade, MALT lymphomas of the gastrointestinal tract. Haematologica 1999; 84:582-8.
50. Klein U, Goossens T, Fischer M, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998; 162:261-80.
51. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998; 95:11816-21.
52. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998; 280: 1750-2.
53. Peng HZ, Du MQ, Koulis A, et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood 1999; 93:2167-72.
54. Muller-Hermelink HK, Greiner A. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am J Pathol 1998; 153:1341-6.
55. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD138/syndecan-1, and Espstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998; 91:747-55.
56. Carbone A, Gloghini A, Gattei V, et al. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 1999; 89:3787-94.
57. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 1995; 147:405-11.
58. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102:1515-25.
59. Capello D, Fais F, Vivenza D, et al. Mutations of BCL-6 and of immunoglobulin variable genes identify distinct molecular subsets of B-cell chronic lymphocytic leukemia and reveals heterogeneity in the histogenesis of the disease. Haematologica 1999; 84(Suppl. to n. 9):7.
60. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-7.
61. Zinzani PL, Magagnoli M, Gherlinzoni F, et al. To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center. Haematologica 1998; 83:502-7.
62. Corradini P, Astolfi M, Cherasco C, et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89:724-31.
63. Freedman AS, Gribben JG, Neuberg D, et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88:2780-6.
64. Price CG, Meerabux J, Murtagh S, et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9:1527-32.
65. Lopez-Guillermo A, Cabanillas F, McLaughlin P, et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood 1998; 91:2955-60.
66. Bendandi M, Gocke CD, Kobrin CB, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999; 5:1171-7.